These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31102655)

  • 41. CRISPR/Cas System for Genome Editing: Progress and Prospects as a Therapeutic Tool.
    Sahel DK; Mittal A; Chitkara D
    J Pharmacol Exp Ther; 2019 Sep; 370(3):725-735. PubMed ID: 31122933
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of genomic sites for CRISPR/Cas9-based genome editing in the Vitis vinifera genome.
    Wang Y; Liu X; Ren C; Zhong GY; Yang L; Li S; Liang Z
    BMC Plant Biol; 2016 Apr; 16():96. PubMed ID: 27098585
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficient Genome Engineering of a Virulent Klebsiella Bacteriophage Using CRISPR-Cas9.
    Shen J; Zhou J; Chen GQ; Xiu ZL
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29899105
    [No Abstract]   [Full Text] [Related]  

  • 44. CRISPR-Cas9: From a bacterial immune system to genome-edited human cells in clinical trials.
    Kick L; Kirchner M; Schneider S
    Bioengineered; 2017 May; 8(3):280-286. PubMed ID: 28287876
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Highly efficient CRISPR/HDR-mediated knock-in for mouse embryonic stem cells and zygotes.
    Wang B; Li K; Wang A; Reiser M; Saunders T; Lockey RF; Wang JW
    Biotechniques; 2015 Oct; 59(4):201-2, 204, 206-8. PubMed ID: 26458548
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Application and optimization of CRISPR/Cas system in bacteria].
    Fu J; Yang F; Xie H; Gu F
    Sheng Wu Gong Cheng Xue Bao; 2019 Mar; 35(3):341-350. PubMed ID: 30912343
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
    Xu R; Wei P; Yang J
    Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Harnessing Type I and Type III CRISPR-Cas systems for genome editing.
    Li Y; Pan S; Zhang Y; Ren M; Feng M; Peng N; Chen L; Liang YX; She Q
    Nucleic Acids Res; 2016 Feb; 44(4):e34. PubMed ID: 26467477
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CRISPR/Cas9-mediated correction of human genetic disease.
    Men K; Duan X; He Z; Yang Y; Yao S; Wei Y
    Sci China Life Sci; 2017 May; 60(5):447-457. PubMed ID: 28534256
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficient genome editing by CRISPR/Cas9 with a tRNA-sgRNA fusion in the methylotrophic yeast Ogataea polymorpha.
    Numamoto M; Maekawa H; Kaneko Y
    J Biosci Bioeng; 2017 Nov; 124(5):487-492. PubMed ID: 28666889
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The prospects of using the technology of genome editing for correction of neurodegenerative diseases.].
    Stepanichev MY
    Adv Gerontol; 2018; 31(6):892-903. PubMed ID: 30877819
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila.
    Xu J; Ren X; Sun J; Wang X; Qiao HH; Xu BW; Liu LP; Ni JQ
    J Genet Genomics; 2015 Apr; 42(4):141-9. PubMed ID: 25953352
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Temperature effect on CRISPR-Cas9 mediated genome editing.
    Xiang G; Zhang X; An C; Cheng C; Wang H
    J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CRISPR-cas System as a Genome Engineering Platform: Applications in Biomedicine and Biotechnology.
    Hashemi A
    Curr Gene Ther; 2018; 18(2):115-124. PubMed ID: 29473500
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.
    Zhang Y; Sastre D; Wang F
    Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gene Editing in Sorghum Through Agrobacterium.
    Sander JD
    Methods Mol Biol; 2019; 1931():155-168. PubMed ID: 30652289
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Research Techniques Made Simple: The Application of CRISPR-Cas9 and Genome Editing in Investigative Dermatology.
    Guitart JR; Johnson JL; Chien WW
    J Invest Dermatol; 2016 Sep; 136(9):e87-e93. PubMed ID: 27542298
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Marker-free genome editing in Ustilago trichophora with the CRISPR-Cas9 technology.
    Huck S; Bock J; Girardello J; Gauert M; Pul Ü
    RNA Biol; 2019 Apr; 16(4):397-403. PubMed ID: 29996713
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genome Editing in Mouse Embryos with CRISPR/Cas9.
    Scott GJ; Gruzdev A
    Methods Mol Biol; 2019; 1960():23-40. PubMed ID: 30798518
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Smart Programmable CRISPR Technology: A Next Generation Genome Editing Tool for Investigators.
    Chakraborty C; Teoh SL; Das S
    Curr Drug Targets; 2017; 18(14):1653-1663. PubMed ID: 27231109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.